The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder
Open accessAbstract
Objective: A recent double-blind randomized placebo-controlled study demonstrated 3-month efficacy and safety of a novel pediatric-appropriate prolonged-release melatonin (PedPRM) for insomnia in children and adolescents with autism spectrum disorder (ASD) and neurogenetic disorders (NGD) with/without attention-deficit/hyperactivity disorder comorbidity. Long-term efficacy and safety of PedPRM treatment was studied. Methods: A prospective, open-label efficacy and safety follow-up of nightly 2, 5, or 10 mg PedPRM in subjects who completed the 13-week double-blind trial (51 PedPRM; 44 placebo). Measures included caregiver-reported Sleep and Nap Diary, Composite Sleep Disturbance Index (CSDI), caregiver's Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale, and quality of life (WHO-5 Well-Being Index). Results: Ninety-five subjects (74.7% males; mean [standard deviation] age, 9 [4.24]; range, 2–17.5 years) received PedPRM (2/5 mg) according to the double-blind phase dose, for 39 weeks with optional dose adjustment (2, 5, or 10 mg/day) after the first 13 weeks. After 52 weeks of continuous treatment (PedPRM-randomized group) subjects slept (mean [SE]) 62.08 (21.5) minutes longer ( p = 0.007); fell asleep 48.6 (10.2) minutes faster ( p < 0.001); had 89.1 (25.5) minutes longer uninterrupted sleep episodes ( p = 0.001); 0.41 (0.12) less nightly awakenings (>50% decrease; p = 0.001); and better sleep quality ( p < 0.001) compared with baseline. The placebo-randomized group also improved with PedPRM. Altogether, by the end of 39-week follow-up, regardless of randomization assignment, 55/72 (76%) of completers achieved overall improvement of ≥1 hour in total sleep time (TST), sleep latency or both, over baseline, with no evidence of decreased efficacy. In parallel, CSDI child sleep disturbance and caregivers' satisfaction of their child's sleep patterns ( p < 0.001 for both), PSQI global ( p < 0.001), and WHO-5 ( p = 0.001) improved in statistically significant and clinically relevant manner ( n = 72) compared with baseline. PedPRM was generally safe; most frequent treatment-related adverse events were fatigue (5.3%) and mood swings (3.2% of patients). Conclusion: PedPRM, an easily swallowed formulation shown to be efficacious versus placebo, is an efficacious and safe option for long-term treatment (up to 52 weeks reported here) of children with ASD and NGD who suffer from insomnia and subsequently improves caregivers' quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“PedPRM has been shown to be efficacious and safe for the long-term treatment of insomnia in children with ASD in initial research [63].”
From Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms (2025) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Test–retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia
Backhaus, J., Junghanns, K., Broocks, A., Riemann, D. W., & Hohagen, F. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00330-6 · Cited by 1,762
Recommendations for a standard research assessment of insomnia
Buysse, D. J., Ancoli-Israel, S., Edinger, J. D., Lichstein, K. L., & Morin, C. M. (2006) · Sleep · doi:10.1093/sleep/29.9.1155 · Cited by 1,206
Bech, P., Olsen, L. R., Kjoller, M., & Rasmussen, N. K. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.145 · Cited by 1,015
Krakowiak, P., Goodlin‐Jones, B. L., Hertz‐Picciotto, I., Croen, L., & Hansen, R. L. (2008) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2008.00650.x · Cited by 589
Abnormal melatonin synthesis in autism spectrum disorders
Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G., Anckarsäter, H., Rastam, M., Ståhlberg, O., Gillberg, I. C., Delorme, R., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002016 · Cited by 511
Melatonin in autism spectrum disorders: a systematic review and meta-analysis
ROSSIGNOL, D. A., & FRYE, R. E. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2011.03980.x · Cited by 468 · cited 1×
“Melatonin treatment has shown promise in the treatment of insomnia in children with neurodevelopmental disabilities (Rossignol and Frye 2011; Cortesi et al. 2012; Gringras et al. 2012).”
BackgroundLeitner, Y. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00268 · Cited by 439 · cited 1×
“Between 30% and 50% of individuals with ASD manifest attention-deficit/ hyperactivity disorder (ADHD) symptoms (particularly at preschool age; Leitner 2014).”
Background
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1111/j.1651-2227.2003.tb00837.x · DOI
Cited by
Sorted by citations
Items 101–176 of 176
Altun, H., & Arslan, S. C. (2024) · European Journal of Therapeutics · doi:10.58600/eurjther1978 · Cited by 3
Insomnia: Is It a Transient Symptom or Long-Lasting Functional Impairment?
Chung, S. (2024) · Sleep Medicine Research · doi:10.17241/smr.2024.02937 · Cited by 3
Autism Spectrum Disorder: Clinical and Genetic Aspects
Shukla, S. (2024) · Current Drug Therapy · doi:10.2174/0115748855313794241108080912 · Cited by 3
Thomas, M., & Shea, S. E. (2025) · Paediatrics & Child Health · doi:10.1093/pch/pxaf107 · Cited by 2
Developmental Processes, Comorbidities, and Quality of Life of Autism Spectrum Disorders
Theodoratou, M., Katsarou, D. V., Mantsos, E., Megari, K., Denazi, E., Papadopoulou, S. L., & Efthymiou, E. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-6405-6.ch013 · Cited by 2
Bruni, O., Mammarella, V., Breda, M., Gringras, P., Malow, B. A., Schaer, M., Schroder, C. M., & Weiss, S. K. (2026) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2026.102286 · Cited by 3
Self-citationMelatonin: Some Aspects of Biochemistry, Physiology, and Pharmacology
Claustrat, B., & Gronfier, C. (2026) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-032-18608-9_4 · Cited by 3
Safety issues regarding melatonin use in child and adolescent patients with sleep problems
Moon, E., & Lee, J. H. (2022) · Kosin Medical Journal · doi:10.7180/kmj.22.142 · Cited by 2
Continuous positive airway pressure as an accurate marker for non‐24‐hour sleep–wake rhythm disorder
Bazin, B., Geoffroy, P. A., Benzaquen, H., Maruani, J., Romier, A., Lejoyeux, M., d’Ortho, M., & Frija‐Masson, J. (2023) · Journal of Sleep Research · doi:10.1111/jsr.13859 · Cited by 2
Joels, H., Benny, A. D. S., Sharpe, A., Postigo, B., Joseph, B., Piantino, C., Marshall, A., Hewertson, V., & Hill, C. M. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.09.020 · Cited by 2
Feitosa, J. S., Barreto, N. A., Andrade, T. S., de Oliveira, G. A., de Oliveira, L. M., & Lima, T. B. (2024) · Research Society and Development · doi:10.33448/rsd-v13i4.45540 · Cited by 2
Nutraceutical approaches for Autism Spectrum Disorder treatment
Dobrachinski, F., Ribeiro, K. A., Bezerra, I. C., da Silva, A. J., Pereira, C. M. M., Vellasques, K., Padilha, H. A., Haas, S. E., Ávila, D. S., & Gubert, P. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115653 · Cited by 2
Pediatric Insomnia: Update and Future Directions
Medalie, L., & Gozal, D. (2018) · Journal of Child Science · doi:10.1055/s-0038-1675222 · Cited by 3
Geoffroy, P. A., Micoulaud‐Franchi, J., Lopez, R., & Schroder, C. M. (2020) · Médecine du Sommeil · doi:10.1016/j.msom.2019.12.185 · Cited by 4
Self-citationPediatric Insomnia: Etiology, Impact, Assessment, and Treatment
Medalie, L., Dang, T., & Casnar, C. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-65574-7_26 · Cited by 4
Quera-Salva, M.-A., Kilic-Huck, Ü., & Vecchierini, M.-F. (2021) · Médecine du Sommeil · doi:10.1016/j.msom.2021.04.002 · Cited by 2
Chen, X., Yang, J., Lv, H., Che, J., Wang, J., Zhang, B., & Shang, P. (2022) · Acta Astronautica · doi:10.1016/j.actaastro.2022.10.020 · Cited by 2
The Treatment of Sleep Problems Using Melatonin
MacLean, J. E., & Malow, B. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-99134-0_15 · Cited by 2
Self-citationImmediate-release supplemental melatonin for delayed sleep phase disorder in children: an overview
Mantle, D. (2019) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2019.15.1.32 · Cited by 2
Edelson, J., Byrnes, J., Mitchell, G. K., Heussler, H., Melaku, M., & Nikles, J. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100530 · Cited by 2
McLellan, E., Haq, I. J., Ebdon, A., Vasey, N., & Anderson, K. N. (2024) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2024-002652 · Cited by 1
Sommeil et neurodéveloppement : un enjeu d’actualité
Langelet, C., & Schroder, C. M. (2025) · Biologie Aujourd hui · doi:10.1051/jbio/2025006 · Cited by 1
Self-citationA scientometric analysis investigating melatonin and cortisol in the context of sleep in autism
Greco, F., Carollo, A., Esposito, G., Mangar, S. A., & Dimitriou, D. (2025) · Research in Autism · doi:10.1016/j.reia.2025.202664 · Cited by 1
Lenker, K., Harvey, A. G., Richdale, A. L., Calo, W., & Fernandez-Mendoza, J. (2026) · Behavioural Sleep Medicine · doi:10.1080/15402002.2026.2658806 · Cited by 1
Sleep in Children with Neurodevelopmental Disorders
Richdale, A. L., Baker, E. K., & Sciberras, E. (2022) · Springer eBooks · doi:10.1007/978-981-19-5791-8_20 · Cited by 1
TRANSTORNOS DO ESPECTRO AUTISTA: MANIFESTAÇÕES NEUROLÓGICAS E TRATAMENTO CLÍNICO
Ribeiro, F. P., Boz, N. W., de Sousa, F. B. R., de Souza, A. L. B. F., & Coelho, R. P. A. (2024) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v9i12.12753 · Cited by 2
Psychopharmakologie in der Kinder- und Jugendpsychiatrie
Kölch, M. G. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-49289-5_69-1 · Cited by 1
CONSUMO DE CÁLCIO EM ESTUDANTES UNIVERSITÁRIOS COM INTOLERÂNCIA À LACTOSE
de Oliveira, L. S., Casaril, K. B. P. B., & Treco, F. R. (2022) · doi:10.22533/at.ed.5922224039 · Cited by 1
Ni, H., Biagini, G., Upadhya, D., & Capuano, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.655290 · Cited by 1
Melatonin for Autism Spectrum Disorder: Beyond Sleep Disturbances?
Siniscalco, D., Antonucci, N., & Rezzani, R. (2018) · Autism - Open Access · doi:10.4172/2165-7890.1000e142
Verbesserter Schlaf für Patienten mit Autismus-Spektrum-Störung
Stollhoff, K. (2018) · Pädiatrie · doi:10.1007/s15014-018-1511-6
Autisme et troubles du sommeil : intérêts de la mélatonine
Thümmler, S., Fernandez, A., Ménard, M.-L., Krieger, V., Dumas, L.-É., David, A., & Askenazy-Gittard, F. (2020) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/s0222-9617(20)30130-6
Vaak voorkomende slaapproblemen bij jonge kinderen
N, D. R., & Deschoemaeker, M. (2020) · JGZ Tijdschrift voor jeugdgezondheidszorg · doi:10.1007/s12452-020-00229-0
Hydzik, H. (2020) · Journal of Restorative Medicine · doi:10.14200/jrm.2020.0103
Autism spectrum disorder and sleep: pharmacology management
Ballester, P., & Peiró, A. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822822-7.00002-8
Sleep in children with genetic disorders
Licis, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822963-7.00224-3
POST COVID-19 ENCEPHALITIS PRESENTING WITH CEREBELLAR SYNDROME
Neto, A. S. D. A., da Nóbrega, A. W., Queiroz, L. P., Neto, Y. C., Leal, E. M., Vieira, G. D. D., Marquardt, M., Cavagnollo, M. T., Freitas, R. G., & de Oliveira, A. D. (2022) · doi:10.22533/at.ed.5922224031
ACOLHIMENTO DE REFUGIADOS: UM RELATO DE EXPERIÊNCIA
Scandiuzzi, S. D. M., & Sanfelice, F. A. N. (2022) · doi:10.22533/at.ed.5922224035
Prolonged-Release Melatonin for Insomnia in Children With ASD
(2020) · AAP Grand Rounds · doi:10.1542/gr.44-3-32
MELATONINO NAUDA VAIKAMS, TURINTIEMS AUTIZMO SPEKTRO SUTRIKIMĄ
Bumblauskytė, V., Jodka, N., & Jotautaitė, N. (2022) · Health Sciences · doi:10.35988/sm-hs.2022.118
Okorie, C. U. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818872-9.00134-5
Rigney, G., Gulati, P., Corkum, P. V., & Weiss, S. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-20792-1_38
Holistic and integrative medicine in the youth athlete
Breuner, C. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99992-2.00082-7
BENEFÍCIOS DA SUPLEMENTAÇÃO DE MELATONINA NO SONO EM CRIANÇAS COM TRANSTORNO DO ESPECTRO AUTISTA
de Oliveira, M. E. G., Lima, J. M. B. D. S., Siqueira, A. L. M. D. O., Souza, J. E. D. S., Costa, D. D. D. M., SILVA, R. R. H. D., Lôbo, G. C. B. C., Martiniano, H. F. D. A., de Souza, M. L. B., & Araújo, A. C. D. P. (2023) · doi:10.56161/sci.ed.20231006c3
Conceptualisations of wellbeing: Through the eyes of primary carers of autistic children
Baird-Bate, K. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.245239
Wewetzer, C., & Warnke, A. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_23
Long-Term Impacts of Exogenous Melatonin Administration in Patients: An Integrative Review
Pacheco, G. M. F., Carvalho, J. C. M., Fernandes, M. J. L., Campagna, L. N., Filgueiras, K. C. G., de Moura, M. F., Bruneli, A. J. N. V., Guizardi, L. F., de Lima, L. P., Afonso, P. C., et al. (2024) · International Journal of Health Science · doi:10.22533/at.ed.1594182409026
The Effect of Melatonin on Metabolism and the Sleep-Wake Cycle
Kurdiukova, D. S., Gasanbekov, G. M., Pavlov, B. V., Kulikova, I. A., Martynova, G. D., & Kislinskaya, N. A. (2024) · Revista de la Universidad del Zulia · doi:10.46925//rdluz.43.09
Sleep and Genetic Neurodevelopmental Disorders
Morse, A. M., & Strong, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-62723-1_16
Psychopharmakologie in der Kinder- und Jugendpsychiatrie
Kölch, M. G. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-66744-6_69
Over-the-Counter Medications and Nutritional Supplements in Child Psychiatry
Hendren, R. L., Spiess, M. I., & Widjaja, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-57472-6_6
Prolonged-Release Melatonin for Sleep Disturbances in Autism Spectrum Disorder
Vivas, E. A., Ron, A. G., Alguacil, E. G., Gascón, M. B., Moreno, M. T. D. S., Cabrera, E. S., Cuevas, G. R.-O. D. L., Peñas, J. J. G., Hoyo, R. S.-D., & Insuga, V. M. S. (2024) · Annals of Child Neurology · doi:10.26815/acn.2024.00682
Keary, C. J., Simon, N., & Tourjee, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-76269-7_5
Melatonin Use as a Dietary Supplement: A Narrative Review of Efficacy and Risks
Park, H. J. (2025) · Food Supplements and Biomaterials for Health · doi:10.52361/fsbh.2025.5.e1
Sleep in People With Intellectual Disabilities
Wiggs, L. D. (2025) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197602751.013.33
Hampshire, P. K., & Elizarraras, J. (2025) · Sleep and Vigilance · doi:10.1007/s41782-025-00309-7
Blouet, C., Moussaoui, E., & Guenolé, F. (2025) · Oxford University Press eBooks · doi:10.1093/oso/9780197635841.003.0030
Bioulac, S. (2025) · Journal de Pédiatrie et de Puériculture · doi:10.1016/j.jpp.2025.08.006
Ipsiroglu, O., & Gober, H.-J. (2025) · Children · doi:10.3390/children12111564
Baker, E. K., Ballester, P., & Richdale, A. L. (2020) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-64802-096-420251004
Richdale, A. L., & Johnson, K. (2020) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-64802-096-420251017
Pharmacological Strategies to Promote Sleep in Children with ASD
Malow, B. A., & McGrew, S. G. (2020) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-64802-096-420251015
Self-citationSadeh, H., Meiri, G., Zigdon, D., Ilan, M., Faroy, M., Michaelovski, A., Sadaka, Y., Dinstein, I., & Menashe, I. (2024) · Figshare · doi:10.6084/m9.figshare.26633283
Kteish, R., Ednick, M., & Kier, C. (2026) · Pediatrics in Review · doi:10.1542/pir.2024-006687
Thomas, M., & Shea, S. E. (2025) · Paediatrics & Child Health · doi:10.1093/pch/pxaf109
Complementary and Alternative Treatments for Autism Spectrum Disorder: A Comprehensive Review
Demir, M. H. B. (2026) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1616996 · Cited by 1
Ezedinma, U., Burgess, S., Jones, E. B. G., Fjaagesund, S., Metse, A. P., Downer, T., & Oprescu, F. (2026) · Current Sleep Medicine Reports · doi:10.1007/s40675-026-00354-2
Vieira-Brinker, A., Wolfson, A., Venta, A., & Alfano, C. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2026.108938
The Pinealoprive Syndrome: Myth or Reality?
Peter‐Derex, L., & Raverot, V. (2026) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-032-18608-9_18
Mundada, S. M., & Zambani, J. (2026) · The Indian Journal of Pediatrics · doi:10.1007/s12098-026-06192-y
Troubles du sommeil et des rythmes circadiens associés aux troubles du spectre de l’autisme
Rabot, E., Chevrot, R.-M., & Schroder, C. M. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78711-9.00024-4
Self-citationBruni, O., Breda, M., Mammarella, V., Polese, D., Mogavero, M. P., Lanza, G., & Ferri, R. (2026) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-026-01513-2
Sleep Management and Recovery After TBI in Kids (SMART-Kids): Pilot Trial Using Melatonin
Williams, C. N., Hall, T. A., Alberts, H., Heierle, J., Lim, M. M., Shea, S. A., & McEvoy, C. T. (2026) · Hospital Pediatrics · doi:10.1542/hpeds.2026-009244
Narakie, K., Ghaneyi, M., & Nourian, Y. H. (2026) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.5812/jjnpp-173406
Clifton, H., & Kamarova, H. (2026) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2026-330942
Metadata
- Authors
- Maras, A., Schroder, C. M., Malow, B. A., Findling, R. L., Breddy, J., Nir, T., Shahmoon, S., Zisapel, N., & Gringras, P.
- Affiliations
- Yulius (NL)
- Centre National de la Recherche Scientifique (FR)
- Vanderbilt University Medical Center (US)
- Kennedy Krieger Institute (US)
- Pharmastat Consulting Ltd.
- Neurim Pharmaceuticals (Israel) (IL)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Corresponding author
- Maras, Athanasios
- ORCID
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2018-12
- Volume
- 28
- Issue
- 10
- Pages
- 699-710
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- PMC
- PMC6306655
- OpenAlex
- W2888600704
- Cited by
- 176
- References
- 44
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 26 · 2023: 23 · 2022: 25 · 2021: 15 · 2020: 28 · 2019: 13 · 2018: 3
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Child and Adolescent Psychopharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- BiblioBoard Library Catalog (Open Research Library) (submittedVersion, cc-by-nc-nd)
- INSAR 2018 Annual Meeting
- Funders
- Children's Hospital of Philadelphia
- University Hospital Southampton NHS Foundation Trust
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083211)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- prolonged-release melatonin, pediatric insomnia, autism spectrum disorder, neurogenetic disorders, ADHD comorbidity, long-term efficacy, sleep quality, sleep latency, total sleep time, sleep disorders, quality of life, children and adolescents, Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index
- MeSH terms
- Autism Spectrum Disorder, Attention Deficit Disorder with Hyperactivity, Central Nervous System Depressants, Child, Communication Disorders, Delayed-Action Preparations, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Sleep Initiation and Maintenance Disorders, Male, Melatonin, Quality of Life, Comorbidity, Treatment Outcome, Drug Monitoring, Polysomnography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
